Junyi Xin

Dr. Junyi Xin


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
MDMulong Du
Mulong Du
RZRui Zheng
Rui Zheng
ZZZhengdong Zhang
Zhengdong Zhang
HCHaiyan Chu
Haiyan Chu
JLJiafei Lu
Jiafei Lu
ZZZhengdong Zhang
Zhengdong Zhang
The biological effects of susceptibility loci are rarely reported in gastric tumorigenesis. We conducted a large-scale cross-ancestry genetic study in 18,852 individuals and identified the potential causal variant rs3850997 T>G at 16p13 significantly associated with a decreased risk of gastric cancer [odds ratio (OR) = 0.87, 95% confidence interval (CI) = 0.83 to 0.91, P = 2.13 × 10−9]. This risk effect was mediated through the mapped long noncoding RNA GCLET (Gastric Cancer Low-Expressed Transcript; ORindirect = 0.987, 95% CI = 0.975 to 0.999, P = 0.018). Mechanistically, rs3850997 exerted an allele-specific long-range regulatory effect on GCLET by affecting the binding affinity of CTCF. Furthermore, GCLET increased FOXP2 expression by competing with miR-27a-3p, and this regulation remarkably affected in vitro, in vivo, and clinical gastric cancer phenotypes. The findings highlight the genetic functions and implications for the etiology and pathology of cancers.

20 December 2023 in Cancer Research
Verified
Journal Article
Closed access
PDF file
MDMulong Du
Mulong Du
JXJunyi Xin
Junyi Xin
RZRui Zheng
Rui Zheng
QYQianyu Yuan
Qianyu Yuan
ZWZhihui Wang
Zhihui Wang
DCDavid C. Christiani
David C. Christiani
Cigarette smoke, containing both nicotine and carcinogens, causes lung cancer. However, not all smokers develop lung cancer, highlighting the importance of the interaction between host susceptibility and environmental exposure in tumorigenesis. Here, we aimed to delineate the interaction between metabolizing ability of tobacco carcinogens and smoking intensity in mediating genetic susceptibility to smoking-related lung tumorigenesis. Single-variant and gene-based associations of 43 tobacco carcinogen–metabolizing genes with lung cancer were analyzed using summary statistics and individual-level genetic data, followed by causal inference of Mendelian randomization, mediation analysis, and structural equation modeling. Cigarette smoke–exposed cell models were used to detect gene expression patterns in relation to specific alleles. Data from the International Lung Cancer Consortium (29,266 cases and 56,450 controls) and UK Biobank (2,155 cases and 376,329 controls) indicated that the genetic variant rs56113850 C>T located in intron 4 of CYP2A6 was significantly associated with decreased lung cancer risk among smokers (OR = 0.88, 95% confidence interval = 0.85–0.91, P = 2.18 × 10−16), which might interact (Pinteraction = 0.028) with and partially be mediated (ORindirect = 0.987) by smoking status. Smoking intensity accounted for 82.3% of the effect of CYP2A6 activity on lung cancer risk but entirely mediated the genetic effect of rs56113850. Mechanistically, the rs56113850 T allele rescued the downregulation of CYP2A6 caused by cigarette smoke exposure, potentially through preferential recruitment of transcription factor helicase-like transcription factor. Together, this study provides additional insights into the interplay between host susceptibility and carcinogen exposure in smoking-related lung tumorigenesis. Significance: The causal pathway connecting CYP2A6 genetic variability and activity, cigarette consumption, and lung cancer susceptibility in smokers highlights the need for behavior modification interventions based on host susceptibility for cancer prevention.

28 April 2023 in Cancer Research
Verified
Journal Article
Closed access
PDF file
SLShuwei Li
Shuwei Li
MDMulong Du
Mulong Du
KXKaili Xu
Kaili Xu
SBShuai Ben
Shuai Ben
TZTianru Zhu
Tianru Zhu
MWMeilin Wang
Meilin Wang
Genetic variants in regions encoding 3′ untranslated regions (UTR) of mRNA potentially alter miRNA binding affinity and N6-methyladenosine (m6A) levels to affect gene expression. A better understanding of the association of these variants with colorectal cancer susceptibility could facilitate development of cancer prevention and treatment approaches. Here, we analyzed miRNA expression profiles and integrated genetic analyses from 8,533 individuals to evaluate the effects of altered miRNA-binding sites on colorectal cancer risk. The single-nucleotide polymorphism rs11245997 in the BET1L 3′UTR was significantly associated with colorectal cancer risk. The rs11245997 A allele facilitated BET1L expression by disrupting miR-140–3p binding. It also reduced BET1L m6A modification, which upregulated BET1L expression levels through a mechanism mediated by the m6A methyltransferases (METTL14 and WTAP) and the m6A demethylase ALKBH5. Moreover, higher expression of BET1L was associated with advanced tumor stages and poor patient prognosis. Increased BET1L expression promoted growth of colorectal cancer cells in vitro and in vivo, which could be partially rescued with miR-140–3p overexpression. RNA sequencing and pathway analyses indicated that BET1L is associated with the steroid biosynthesis pathway through regulation of HSD17B7, CYP27B1, and COMT. These findings provide insights into the involvement of genetic variants of BET1L in the development and progression of colorectal cancer. Significance: The integration of miRNA expression profiles and genetic variants identified rs11245997 as a colorectal cancer risk-related variant that reduces miR-140–3p binding and m6A modification, leading to BET1L upregulation to promote colorectal tumorigenesis.

6 July 2021 in eLife
Verified
Journal Article
Open access
HLHui Liu
Hui Liu
JXJunyi Xin
Junyi Xin
SCSheng Cai
Sheng Cai
XJXia Jiang
Xia Jiang
Background: To understand a causal role of modifiable lifestyle factors in angiotensin-converting enzyme 2 (ACE2) expression (a putative severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2] receptor) across 44 human tissues/organs, and in coronavirus disease 2019 (COVID-19) susceptibility and severity, we conducted a phenome-wide two-sample Mendelian randomization (MR) study.Methods: More than 500 genetic variants were used as instrumental variables to predict smoking and alcohol consumption. Inverse-variance weighted approach was adopted as the primary method to estimate a causal association, while MR-Egger regression, weighted median, and MR pleiotropy residual sum and outlier (MR-PRESSO) were performed to identify potential horizontal pleiotropy.Results: We found that genetically predicted smoking intensity significantly increased ACE2 expression in thyroid (β=1.468, p=1.8×10−8), and increased ACE2 expression in adipose, brain, colon, and liver with nominal significance. Additionally, genetically predicted smoking initiation significantly increased the risk of COVID-19 onset (odds ratio=1.14, p=8.7×10−5). No statistically significant result was observed for alcohol consumption.Conclusions: Our work demonstrates an important role of smoking, measured by both status and intensity, in the susceptibility to COVID-19.Funding: XJ is supported by research grants from the Swedish Research Council (VR-2018–02247) and Swedish Research Council for Health, Working Life and Welfare (FORTE-2020–00884).

9 December 2025 in American Journal of Preventive Cardiology
Verified
Journal Article
Open access
TXTingting Xu
Tingting Xu
JWJin Wei
Jin Wei
MXMing Xu
Ming Xu
HLHuiqin Li
Huiqin Li
SCSilu Chen
Silu Chen
MDMulong Du
Mulong Du
Cardiovascular–kidney–metabolic (CKM) syndrome poses a critical challenge for public health. However, its association with mortality risk remain inadequately characterized. 282,952 participants at baseline from the UK Biobank were monitored until November 12, 2021. Cox regression analyses evaluated the associations between CKM stages and the risk of all-cause and cause-specific mortality, including cardiovascular diseases (CVD), cancer, respiratory diseases, and digestive system diseases. Over a median follow-up of 12.7 years, 16,834 deaths occurred, including 15.8% from CVD, 50.3% from cancer, 6.0% from respiratory diseases, 3.6% from digestive system diseases, and 24.3% from other causes. The risk of all-cause, cancer, CVD, respiratory, and digestive mortality increased with advancing CKM stages (P < 0.001). Compared with Stage 0, the hazard ratios (HR) in Stage 4 were 2.34 (95% confidence interval [CI]: 2.11–2.58) for all-cause mortality, 10.15 (95% CI: 6.92–14.89) for CVD mortality, and 1.41 (95% CI: 1.23–1.62) for cancer mortality. Furthermore, younger adults (aged ≤ 60 years; Pinteraction < 0.001) had stronger associations with all-cause, CVD, cancer, and respiratory events. Significant associations were observed between current smoking and cancer mortality (Pinteraction < 0.001), and between previous smoking and all-cause and CVD mortality (Pinteraction < 0.001). CKM stages are strongly associated with increased all-cause and cause-specific mortality. Early identification and intervention in CKM syndrome patients could be crucial for reducing premature mortality and improving public health.

8 December 2025 in Archives of Toxicology
Verified
Journal Article
Closed access
PDF file
WWWei Wang
Wei Wang
HLHuiqin Li
Huiqin Li
LGLei Gao
Lei Gao
BLBingxin Liu
Bingxin Liu
SCSilu Chen
Silu Chen
MDMulong Du
Mulong Du